Abbott Laboratories (ABT) Q1 2024 Earnings Call Transcript
https://www.fool.com/earnings/call-transcripts/2024/04/17/abbott-laboratories-abt-q1-2024-earnings-call-tran/?source=iedfolrf0000001
Apr 17, 2024 - ABT earnings call for the period ending March 31, 2024.
0
Abbott (ABT) Q1 Earnings Beat Estimates, Margins Contract
https://www.zacks.com/stock/news/2256957/abbott-abt-q1-earnings-beat-estimates-margins-contract?cid=CS-ZC-FT-analyst_blog|earnings_article-2256957
Apr 17, 2024 - Abbott (ABT) delivers double-digit organic sales growth in its underlying base business in the first quarter of 2024.
0
5 stocks to watch on Wednesday: LLY, ABT and more
https://seekingalpha.com/news/4090463-5-stocks-to-watch-on-wednesday-lly-abt-and-more?source=feed_sector_healthcare
Apr 17, 2024 - Eli Lilly (LLY), Abbott Laboratories (ABT), Travelers (TRV), Capri (CPRI) and Tapestry (TPR) are the stocks to watch on Wednesday.
0
What's in Store for Abbott Laboratories (ABT) in Q1 Earnings?
https://www.zacks.com/stock/news/2254571/what-s-in-store-for-abbott-laboratories-abt-in-q1-earnings?cid=CS-ZC-FT-analyst_blog|earnings_preview-2254571
Apr 12, 2024 - Abbott (ABT) is likely to have progressed with its initiative to commercialize several biosimilars in emerging markets.
0
Abbott (ABT) Rises Higher Than Market: Key Facts
https://www.zacks.com/stock/news/2252958/abbott-abt-rises-higher-than-market-key-facts?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_6v1-2252958
Apr 09, 2024 - The latest trading day saw Abbott (ABT) settling at $112.44, representing a +1.74% change from its previous close.
0
HAE vs. ABT: Which Stock Is the Better Value Option?
https://www.zacks.com/stock/news/2252781/hae-vs-abt-which-stock-is-the-better-value-option?cid=CS-ZC-FT-tale_of_the_tape|yseop_template_3-2252781
Apr 09, 2024 - HAE vs. ABT: Which Stock Is the Better Value Option?
0
Abbott (ABT) Faces Low Testing Demand, Currency Headwinds
https://www.zacks.com/stock/news/2251992/abbott-abt-faces-low-testing-demand-currency-headwinds?cid=CS-ZC-FT-analyst_blog|zer_report_update-2251992
Apr 08, 2024 - Abbott's (ABT) core laboratory diagnostics business is gaining strength on the continued success of the Alinity suite of diagnostics instruments, along with a broad test menu offering.
0
The Zacks Analyst Blog Highlights T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services
https://www.zacks.com/stock/news/2251993/the-zacks-analyst-blog-highlights-t-mobile-us-abbott-laboratories-palo-alto-networks-enterprise-products-partners-and-the-pnc-financial-services?cid=CS-ZC-FT-press_releases-2251993
Apr 08, 2024 - T-Mobile US, Abbott Laboratories, Palo Alto Networks, Enterprise Products Partners and The PNC Financial Services are part of the Zacks top Analyst Blog.
0
Top Analyst Reports for T-Mobile US, Abbott Laboratories & Palo Alto Networks
https://www.zacks.com/commentary/2251046/top-analyst-reports-for-t-mobile-us-abbott-laboratories-palo-alto-networks?cid=CS-ZC-FT-research_daily-2251046
Apr 05, 2024 - Today's Research Daily features new research reports on 16 major stocks, including T-Mobile US, Inc. (TMUS), Abbott Laboratories (ABT) and Palo Alto Networks, Inc. (PANW).
0
Abbott (ABT) Receives FDA's Approval for the TriClip TEER System
https://www.zacks.com/stock/news/2251212/abbott-abt-receives-fda-s-approval-for-the-triclip-teer-system?cid=CS-ZC-FT-analyst_blog|company_news_-_medical_sector-2251212
Apr 05, 2024 - Abbott (ABT) receives FDA nod for TriClip, a first-of-its-kind device to repair a leaky tricuspid heart valve.
0
Page 1>